September 5, 2025

EyePoint Pharmaceuticals, Inc. (EYPT) Investor Outlook: Unpacking a 189.70% Upside Potential

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) stands out in the biotechnology sector with its focus on developing innovative therapeutics for serious retinal diseases. With a market cap..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A 23% Potential Upside in the Biotech Sector

For investors keeping tabs on the biotechnology sector, Stoke Therapeutics, Inc. (NASDAQ: STOK) stands out as a compelling opportunity with its innovative approach to treating severe..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 477% Upside in Biotech Innovation

Humacyte, Inc. (HUMA), a pioneering biotechnology company based in Durham, North Carolina, is gaining attention for its cutting-edge work in bioengineered human tissues. With a market..

Altimmune, Inc. (ALT) Stock Analysis: Exploring a 383% Potential Upside in Biotech

Altimmune, Inc. (NASDAQ: ALT) stands as a compelling entity within the healthcare sector, specifically in the biotechnology industry. With a current market capitalization of $314.2 million,..

Autolus Therapeutics plc (AUTL): Exploring a Potential 563.60% Upside in the Biotech Arena

Autolus Therapeutics plc (NASDAQ: AUTL), a prominent player in the biotechnology sector, has captured investor attention with a staggering potential upside of 563.60%. Headquartered in London,..

Sage Therapeutics, Inc. (SAGE) Stock Analysis: Is This Biotech Innovator in Your Portfolio’s Future?

Sage Therapeutics, Inc. (NASDAQ: SAGE) stands as a notable player in the biotechnology sector, focused on pioneering treatments for brain health. Operating out of Cambridge, Massachusetts,..

Precigen, Inc. (PGEN) Stock Analysis: 80% Upside Potential Amid Innovative Biotech Advances

Precigen, Inc. (NASDAQ: PGEN) is emerging as a noteworthy contender in the biotechnology sector, offering substantial growth opportunities for investors. With a market capitalization of $1.36..

Arvinas, Inc. (ARVN) Stock Analysis: Biotechnology Innovator with 142% Potential Upside

Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its innovative approach to drug development. Specializing in the..

ATAI Life Sciences N.V. (ATAI) Stock Analysis: A Biotech with 147% Potential Upside and Promising Mental Health Innovations

ATAI Life Sciences N.V. (NASDAQ: ATAI), a German-based biotechnology company, is capturing significant attention in the healthcare sector. Specializing in developing treatments for mental health conditions,..

Verve Therapeutics, Inc. (VERV) Stock Analysis: Unpacking a 17.92% Potential Upside in the Biotech Sector

As the biotech sector continues to captivate investors with groundbreaking innovations, Verve Therapeutics, Inc. (NASDAQ: VERV) stands out as a promising name with a potential upside..

Abivax SA (ABVX) Stock Analysis: Biotechnology Innovator with 13.38% Potential Upside

Investors eyeing the biotechnology sector may want to turn their attention to Abivax SA (ABVX), a French clinical-stage company with a focus on innovative therapeutics. With..

Definitive Healthcare Corp. (DH) Stock Analysis: A 13% Potential Upside Amidst Market Challenges

Definitive Healthcare Corp. (NASDAQ: DH) presents a compelling investment case for those navigating the volatile healthcare sector. As a provider of a comprehensive SaaS healthcare commercial..

AngioDynamics, Inc. (ANGO): A Healthcare Innovator with Notable 70% Upside Potential

For investors with an eye on the healthcare sector, AngioDynamics, Inc. (NASDAQ: ANGO) presents a compelling opportunity. The Latham, New York-based medical technology company is carving..

Owens & Minor, Inc. (OMI) Stock Analysis: Assessing Growth Potential Amidst Healthcare Sector Challenges

Owens & Minor, Inc. (NYSE: OMI), a longstanding player in the medical distribution industry, continues to navigate the complexities of the healthcare sector with a focus..

Auna SA (AUNA) Stock Analysis: Healthcare Player with a Promising 89.99% Upside Potential

Auna SA (AUNA), a Luxembourg-based healthcare service provider, is capturing the attention of investors with its promising upside potential. Operating a network of hospitals and clinics..

RxSight, Inc. (RXST) Stock Analysis: Navigating the Healthcare Sector with a Focus on Innovative Cataract Solutions

RxSight, Inc. (NASDAQ: RXST), a pioneering player in the healthcare sector, specifically within the medical devices industry, offers a promising yet challenging landscape for investors. Known..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 190% Upside in the Biotech Sector

Sana Biotechnology, Inc. (SANA), a prominent player in the healthcare sector, specifically within the biotechnology industry, has been capturing investor attention with its innovative approach to..

Bicara Therapeutics Inc. (BCAX): Investor Outlook on an Emerging Biotech with 173% Upside Potential

Bicara Therapeutics Inc. (BCAX) is making waves in the biotechnology sector with its innovative approach to cancer treatment. Based in Boston, Massachusetts, this clinical-stage biopharmaceutical company..

Emergent BioSolutions (EBS) Stock Insights: Exploring a 76.93% Potential Upside

Emergent BioSolutions Inc. (NYSE: EBS), a company with a pivotal role in public health preparedness and response, is currently capturing investor attention with a potential upside..

Investor Outlook: Akso Health Group (AHG) Shows Remarkable Revenue Growth Amidst Volatile Market Conditions

Akso Health Group (AHG), a burgeoning player in the Healthcare sector, is making waves with its impressive revenue growth, despite the challenges it faces in the..

Search

Funds

September 5, 2025

Search

Funds

September 5, 2025

FTSE 100

Funds